Original language | English (US) |
---|---|
Pages (from-to) | 1070-1076.e3 |
Journal | Gastroenterology |
Volume | 165 |
Issue number | 4 |
DOIs | |
State | Published - Oct 2023 |
ASJC Scopus subject areas
- Hepatology
- Gastroenterology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Gastroenterology, Vol. 165, No. 4, 10.2023, p. 1070-1076.e3.
Research output: Contribution to journal › Short survey › peer-review
}
TY - JOUR
T1 - Elucidating the Risk of Colorectal Cancer for Variants in Hereditary Colorectal Cancer Genes
AU - Gecco-Ccfr Consortium
AU - Mahmood, Khalid
AU - Thomas, Minta
AU - Qu, Conghui
AU - Wang, Xiaoliang
AU - Huyghe, Jeroen R.
AU - Joo, Jihoon E.
AU - Georgeson, Peter
AU - Arndt, Volker
AU - Berndt, Sonja I.
AU - Bézieau, Stéphane
AU - Bien, Stephanie A.
AU - Bishop, D. Timothy
AU - Brenner, Hermann
AU - Brezina, Stefanie
AU - Burnett-Hartman, Andrea
AU - Campbell, Peter T.
AU - Casey, Graham
AU - Castellví-Bel, Sergi
AU - Chan, Andrew T.
AU - Chang-Claude, Jenny
AU - Chen, Xuechen
AU - Conti, David V.
AU - Cremolini, Chiara
AU - Diergaarde, Brenda
AU - Figueiredo, Jane C.
AU - FitzGerald, Liesel M.
AU - Gago-Dominguez, Manuela
AU - Gallinger, Steven
AU - Giles, Graham G.
AU - Gsu, Andrea
AU - Gunter, Marc J.
AU - Hampe, Jochen
AU - Hampel, Heather
AU - Harrison, Tabitha A.
AU - Hoffmeister, Michael
AU - Keku, Temitope O.
AU - Kundaje, Anshul
AU - Le Marchand, Loic
AU - Lenz, Heinz Josef
AU - Li, Christopher I.
AU - Li, Li
AU - Lin, Yi
AU - Lindblom, Annika
AU - Moreno, Victor
AU - Murphy, Neil
AU - Newcomb, Polly A.
AU - Newton, Christina C.
AU - Obón-Santacana, Mireia
AU - Ogino, Shuji
AU - Pai, Rish K.
N1 - Funding Information: ColoCare: This work was supported by the NIH (grant numbers R01 CA189184 [Christopher Li and Cornelia M. Ulrich], U01 CA206110 [Cornelia M. Ulrich, Christopher Li, Erin Siegel, Jane C. Figueiredo, and Graham Colditz], R01 CA207371 [Cornelia M. Ulrich and Christopher Li]), the Matthias Lackas-Foundation, the German Consortium for Translational Cancer Research, and the European Union TRANSCAN initiative. Funding Information: Czech Republic CCS: This work was supported by the Grant Agency of the Czech Republic (20-03997S), by the grants AZV NV18/03/00199, and by Charles University grants Unce/Med/006 and Progress Q28/LF1. Funding Information: NSHDS: The investigators thank the Västerbotten Intervention Programme, the Northern Sweden MONICA study, the Biobank Research Unit at Umeå University, and Biobanken Norr at Region Västerbotten for providing data and samples and acknowledge the contribution from Biobank Sweden, supported by the Swedish Research Council . Funding Information: DACHS: This work was supported by the German Research Council (BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, CH 117/1-1, HO 5117/2-1, HE 5998/2-1, KL 2354/3-1, RO 2270/8-1, and BR 1704/17-1); the Interdisciplinary Research Program of the National Center for Tumor Diseases, Germany; and the German Federal Ministry of Education and Research (01KH0404, 01ER0814, 01ER0815, 01ER1505A, and 01ER1505B). Funding Information: Colorectal Cancer Genetics & Genomics (CRCGEN): Colorectal Cancer Genetics and Genomics, Spanish study was supported by Instituto de Salud Carlos III , cofunded by European Regional Development Fund (FEDER) funds—A Way to Build Europe (grants PI14-613 and PI09-1286), the Agency for Management of University and Research Grants (AGAUR) of the Catalan Government (grant 2017SGR723), Junta de Castilla y León (grant LE22A10-2), and Spanish Association Against Cancer Scientific Foundation grants POSTD037OBON and GCTRA18022MORE. Sample collection of this work was supported by the Xarxa de Bancs de Tumors de Catalunya sponsored by Pla Director d’Oncología de Catalunya, Plataforma Biobancos PT13/0010/0013 and ICOBIOBANC, sponsored by the Catalan Institute of Oncology. Funding Information: EDRN: This work is funded and supported by the NCI, EDRN grant U01 CA152753. Funding Information: Cancer Prevention Study-II (CPS-II): The authors thank the CPS-II participants and Study Management Group for their invaluable contributions to this research. The authors would also like to acknowledge the contribution to this study from central cancer registries supported through the Centers for Disease Control and Prevention National Program of Cancer Registries and cancer registries supported by the National Cancer Institute Surveillance Epidemiology and End Results program. Funding Information: CORSA: The CORSA study was funded by Austrian Research Funding Agency BRIDGE (grant 829675, to Andrea Gsur) and the “Herzfelder’sche Familienstiftung” (grant to Andrea Gsur) and was supported by European Cooperation in Science and Technology (COST) Action BM1206. Funding Information: Daniel D. Buchanan is supported by an NHMRC Emerging Leadership Investigator grant (GNT1194896), University of Melbourne Dame Kate Campbell Fellowship, and funding from the University of Melbourne Research at Melbourne Accelerator Program. Peter Georgeson is supported by an Australian Government Research Training Program Scholarship. Funding Information: ASTERISK: a Hospital Clinical Research Program (PHRC-BRD09/C) from the University Hospital Center of Nantes and supported by the Regional Council of Pays de la Loire , the Groupement des Entreprises Françaises dans la Lutte contre le Cancer (GEFLUC), the Association Anne de Bretagne Génétique and the Ligue Régionale Contre le Cancer (LRCC). Funding Information: CLUE II funding was from the NCI (U01 CA86308, Early Detection Research Network; P30 CA006973), National Institute on Aging (U01 AG18033), and the American Institute for Cancer Research. The content of this publication does not necessarily reflect the views or policies of the US Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US government. Maryland Cancer Registry Cancer data were provided by the Maryland Cancer Registry, Center for Cancer Prevention and Control, and Maryland Department of Health, with funding from the State of Maryland and the Maryland Cigarette Restitution Fund. The collection and availability of cancer registry data are also supported by Cooperative Agreement NU58DP006333, funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the US Department of Health and Human Services. Funding Information: COLON: The COLON study is sponsored by Wereld Kanker Onderzoek Fonds , including funds from grant 2014/1179 as part of the World Cancer Research Fund International Regular Grant Programme, by Alpe d’Huzes and the Dutch Cancer Society (UM 2012–5653, UW 2013-5927, UW2015-7946), by TRANSCAN (JTC2012-MetaboCCC, JTC2013-FOCUS) and by RegioDeal Foodvalley (grant number 162135). The Nqplus study is sponsored by a ZorgOnderzoek Nederland/Medical Sciences (ZonMW) investment grant (98-10030); by the Prevention of Diabetes Through Lifestyle Intervention and Population Studies in Europe and Around the World (PREVIEW) project, which received funding from the European Union Seventh Framework Programme (FP7/2007–2013) under grant number 312057; by funds from Top Institute Food and Nutrition (cardiovascular health theme), a public–private partnership on precompetitive research in food and nutrition; and by FOODBALL, the Food Biomarker Alliance, a project from Joint Program Initiative Healthy Diet for a Healthy Life. Funding Information: WHI: The WHI program is funded by the National Heart, Lung, and Blood Institute, NIH, US Department of Health and Human Services through contracts HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, and HHSN271201100004C. Funding Information: Funding This work was funded by the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO): National Cancer Institute (NCI), National Institutes of Health (NIH), and US Department of Health and Human Services (R01 CA059045, U01 CA164930, R01201407, R01CA248857, R01 CA206279, R01 CA244588, and R21 CA230486). This research was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA015704. Scientific Computing Infrastructure at Fred Hutchinson Cancer Center funded by Office of Research Infrastructure Programs (ORIP) grant S10OD028685. Funding Information: PLCO: The authors thank the PLCO Cancer Screening Trial screening center investigators and the staff from Information Management Services Inc and Westat Inc. Most importantly, we thank the study participants for their contributions that made this study possible. Cancer incidence data have been provided by the District of Columbia Cancer Registry, Georgia Cancer Registry, Hawaii Cancer Registry, Minnesota Cancer Surveillance System, Missouri Cancer Registry, Nevada Central Cancer Registry, Pennsylvania Cancer Registry, Texas Cancer Registry, Virginia Cancer Registry, and Wisconsin Cancer Reporting System. All are supported in part by funds from the Centers for Disease Control and Prevention, National Program for Central Registries, local states, or the National Cancer Institute’s Surveillance, Epidemiology, and End Results program. The results reported here and the conclusions derived are the sole responsibility of the authors. Funding Information: BWHS is funded by NIH U01CA164974. Funding Information: The Colon Cancer Family Registry (CCFR) ( https://www.coloncfr.org ) is supported in part by funding from the NCI, NIH (award U01 CA167551). Support for case ascertainment was provided in part from the Surveillance, Epidemiology, and End Results (SEER) Program; the following US state cancer registries: Arizona, Colorado, Minnesota, North Carolina, and New Hampshire; and the Victoria Cancer Registry (Australia) and Ontario Cancer Registry (Canada). The CCFR Set-1 (Illumina 1M/1M-Duo) and Set-2 (Illumina Omni1-Quad) scans were supported by NIH awards U01 CA122839 and R01 CA143237 (to Graham Casey). The CCFR Set-3 (Affymetrix Axiom CORECT Set array) was supported by NIH award U19 CA148107 and R01 CA81488 (to Stephen B. Gruber). The CCFR Set-4 (Illumina OncoArray 600K SNP array) was supported by NIH award U19 CA148107 (to Stephen B. Gruber) and by the Center for Inherited Disease Research, which is funded by the NIH to Johns Hopkins University, contract number HHSN268201200008I. Additional funding for the OFCCR/ARCTIC was through a Cancer Risk Evaluation (CaRE) Program grant from the Canadian Cancer Society (to Steven Gallinger), and through generous support from the Ontario Ministry of Research and Innovation . The SFCCR Illumina HumanCytoSNP array was supported in part through NCI/NIH awards U01/U24 CA074794 and R01 CA076366 (to Polly A. Newcomb). The content of this manuscript does not necessarily reflect the views or policies of the NCI, NIH, or any of the collaborating centers in the Colon Cancer Family Registry (CCFR), nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government, any cancer registry, or the CCFR. Funding Information: Colorectal Cancer Transdisciplinary (CORECT) study: The CORECT study was supported by the NCI/NIH, US Department of Health and Human Services (grant numbers U19 CA148107, R01 CA81488, P30 CA014089, R01 CA197350, P01 CA196569, R01 CA201407, U19 CA148107, R01 CA242218) and National Institutes of Environmental Health Sciences, NIH (grant number T32 ES013678).
PY - 2023/10
Y1 - 2023/10
UR - http://www.scopus.com/inward/record.url?scp=85169790437&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85169790437&partnerID=8YFLogxK
U2 - 10.1053/j.gastro.2023.06.032
DO - 10.1053/j.gastro.2023.06.032
M3 - Short survey
C2 - 37453563
AN - SCOPUS:85169790437
SN - 0016-5085
VL - 165
SP - 1070-1076.e3
JO - Gastroenterology
JF - Gastroenterology
IS - 4
ER -